In the last several years, the global healthcare ecosystem has witnessed the development of several treatments for epilepsy, with new medications proving to be more and more efficient. Though researchers have learned the root causes of epilepsy, they continue to evaluate new treatment methods. In the United States alone, 34 million people have epilepsy, and with proper treatment, most of these patients can actually live healthy lives without having seizures.
Patients today demand epilepsy medication that should free them from seizures while not causing any unacceptable side effects. Medical researchers are currently developing medications that effectively stop the occurrence of seizures without generating side effects. The drugs available today in the market are easier to use and more predictable and generate excellent results. The drug Epidiolex, for example, made from medical marijuana, is highly effective in treating severe seizures. Apart from medicines, there are several implantable medical devices that are becoming popular as effective alternatives.
Devices such as Vagus Nerve Stimulator (VNS) and NeuroPace are prevalent among epilepsy patients. VNS therapy sends electrical pulses to the vagus nerve on the neck. Though it is not clear how this therapy prevents seizures, it is believed that the device blocks certain brain impulses that directly induce seizures. NeuroPace, on the other hand, is a reactive stimulator that detects seizures and shocks the brain to stop them.
Several researchers today are working on the genetics of epilepsy. Do the global healthcare community already knows that genes cause rare forms of epilepsy, what they do not know is which genes are involved in the process. Once researchers are able to identify the genes, the landscape of epilepsy treatment will be revolutionized for good. The bottom line is that patients are required to undergo regular checkups to ensure that their treatments are effective and the occurrence of seizures is reduced.